Subscribe
Share
Share
Embed
L'Oréal's CEO names GLP-1 drugs as a force reshaping beauty sales, Italy's IAP censures Magic Magnesium Malate, Biotiful rebrands, and Jocko Fuel rolls into Target.
L'Oréal's CEO just flagged GLP-1 drugs as a structural demand shift hitting beauty and skincare. If you sell supplements or functional food, this wave is already reaching your shelf.
In this episode:
The Health Marketing Daily is a concise briefing for marketers and founders in supplements, functional food and consumer health, hosted by Marco & Klara. New episode every day.
Enjoying the show? A quick rating or review on Apple Podcasts or Spotify helps other marketers find us.
Also from Marco & Klara: The FMCG Marketing Daily · The Digital Commerce Daily
The daily briefing for professionals in health, nutrition, and wellness marketing. Every episode covers an ingredient of the day, the latest science and regulatory updates from EFSA and beyond, and the brand and market moves shaping the nutraceutical industry. Hosted by Klara and Marco — evidence-based, no hype, no bro-science. Built for formulators, brand managers, regulatory affairs teams, and anyone building in the health and nutrition space.
Marco: Four strong stories on the agenda today.
Klara: We're starting in Italy, where an advertising watchdog has just slapped down a magnesium supplement brand for overclaiming on sleep and restless legs.
Marco: Then L'Oréal's CEO is talking GLP-1 drugs and what they mean for beauty sales — big implications for wellness brands.
Klara: Plus a kefir brand refresh and a US sports nutrition brand rolling into Target.
Marco: Let's get into it.
Marco: Italy's advertising watchdog has just slapped down a magnesium supplement brand for claims it never quite made — but clearly implied.
Marco: Magnesium is everywhere in European supplement marketing right now. Sleep, muscle recovery, restless legs — it's one of the most heavily promoted ingredients on shelves from Milan to Munich. That popularity makes it a target for regulatory scrutiny.
Marco: Italy's IAP — that's the Istituto dell'Autodisciplina Pubblicitaria, the country's self-regulatory advertising body — censured the brand Magic Magnesium Malate. The ruling found that the advertising implied benefits for restless legs syndrome and improved sleep, without adequate scientific evidence to back those suggestions up. No direct claim was made. But the overall message led consumers to expect a therapeutic outcome. That was enough for the IAP to act.
Klara: This is the part marketers often miss. Under EU rules — specifically EC 1924/2006, which governs health claims across Europe — it doesn't matter whether you state a benefit explicitly. If your imagery, copy, and overall framing together suggest a health outcome, that counts as a claim. Magnesium does have EFSA-authorised claims, but they cover things like normal muscle function and reduction of tiredness. Restless legs and sleep improvement? Not on the approved list.
Marco: Commercially, I understand the temptation. Sleep and restless legs are huge consumer concerns. Brands want to speak to those anxieties. But this ruling should make any marketer nervous about using soft language and evocative visuals as a workaround.
Klara: It's not a workaround. It's a liability. And Italian precedents travel. Other European self-regulatory bodies watch each other's decisions closely.
Marco: So if your magnesium campaign is doing a lot of heavy lifting through suggestion rather than substance, now is a very good time to review it.
Marco: Let's move to our next story.
Klara: L'Oréal's CEO has put GLP-1 weight-loss drugs on the beauty industry's strategic radar — and the implications stretch well beyond lipstick sales.
Klara: GLP-1 drugs — medications like semaglutide that suppress appetite and drive significant weight loss — have already disrupted food, supplements, and grocery. Now they're visibly reshaping beauty purchasing patterns. When one of the world's largest beauty companies flags a structural demand shift, the whole wellness sector should pay attention.
Klara: L'Oréal's CEO described GLP-1 adoption as a "very important phenomenon" actively influencing how consumers buy beauty and skincare products. No precise revenue figure was attached, but the language was clear — this is not a peripheral trend. It's showing up in mass-market retail data at scale.
Klara: From a science perspective, the link makes sense. Rapid weight loss changes skin behaviour. Fat loss reduces subcutaneous support under the skin. That accelerates the appearance of sagging and fine lines. On top of that, lower calorie intake often means lower intake of key nutrients — collagen precursors, ceramide-supporting fatty acids, vitamins A and C. Skin-from-within supplements have a genuinely credible story to tell here, provided the claims stay within EFSA-authorised boundaries.
Marco: And that's exactly where the commercial opportunity sits. The GLP-1 consumer is already engaged with their health journey. They're receptive. Brands selling collagen, ceramides, or targeted skin nutrition can position alongside that journey — not against it. Boots and dm both carry strong skin supplement ranges. This is the moment to sharpen that positioning with real intent.
Klara: My concern is brands rushing to slap "GLP-1 support" on packaging without the clinical grounding to justify it. That framing needs to hold up to scrutiny.
Marco: Noted — and fair. The story needs evidence behind it, not just momentum.
Klara: Now, let's move to our next story.
Marco: Biotiful Gut Health has just overhauled its entire brand identity and packaging — and it's worth unpacking why that matters.
Marco: Kefir — a fermented dairy drink with genuine research behind its microbiome benefits — has been quietly building shelf presence in UK retail for several years. But the gut health category has become seriously crowded. New functional food and drink brands are landing in Boots, Waitrose, and Sainsbury's almost monthly. Standing still visually is no longer an option.
Marco: Biotiful has redesigned packaging across its full product range. This is a complete portfolio refresh, not a single SKU tweak. The goal is clearly to sharpen its positioning as the category leader in UK kefir — and to hold that ground as competition intensifies.
Marco: Commercially, this is a smart defensive move. Kefir occupies a genuinely unusual space — it lives in the chilled dairy aisle, but it competes functionally with probiotic supplements. That dual identity is both an asset and a problem. Consumers browsing for gut health solutions might walk straight past a dairy brand without making that mental connection. Strong, purposeful packaging is how you close that gap.
Klara: The science actually supports Biotiful's ambition here. Fermented dairy products like kefir have a reasonable evidence base for microbiome support. The clinical literature on live cultures and gut function is more credible than a lot of what you find in the supplement aisle. But — and this is where I'd push back slightly — that evidence still needs to translate into compliant claims. "Gut health" as a phrase on pack is not automatically EFSA-authorised. The specific permitted claims relate to live cultures and lactose digestion. Vague wellness language remains risky.
Marco: That's a real tension for the category, not just for Biotiful. The science is there, but the approved claim vocabulary barely does it justice.
Klara: Which is exactly why packaging design becomes so strategically loaded. It has to carry meaning the words can't legally say.
Marco: Right — onto our final story now.
Klara: A US military-identity protein brand just landed a nationwide deal with one of America's biggest mass retailers — and it's a useful signal for anyone building sports nutrition brands in Europe.
Klara: Sports nutrition used to live in specialist channels — dedicated supplement shops, gym counters, online direct-to-consumer. That's changed. Mass retail is now the primary growth arena, and the brands winning shelf space aren't always the ones with the most sophisticated formulas.
Klara: Jocko Fuel — co-founded by retired Navy SEAL and podcaster Jocko Willink — is rolling its protein shakes and powders into Target stores across the US. Target runs over 1,900 locations and carries serious health and wellness footfall. This puts Jocko Fuel directly alongside established sports nutrition names in a channel that moves enormous volume.
Klara: From a science angle, what's striking is how little the conversation around this launch centres on formulation. The brand's credibility is built on its founder's identity — military discipline, podcasting community, authenticity. That's doing the heavy lifting, not clinical differentiation.
Marco: And that's not a criticism — it's a blueprint. Founder-led brands with genuine communities behind them are now landing mass-retail listings in a fraction of the time traditional brands needed. We're seeing the same logic play out in the UK and Germany. Boots and Tesco aren't just stocking brands with great specs anymore. They want brands that arrive with audiences already attached.
Klara: My hesitation is what happens at shelf without that podcast ecosystem around you. A founder story that converts brilliantly in a sixty-minute audio format is incredibly hard to compress onto a 10cm product label.
Marco: That's the real design challenge — and most brands don't solve it until it's too late. Mass retail is unforgiving if the packaging can't carry the story alone.
Marco: Today's throughline is clear — the brands winning right now are the ones that earn their place on shelf and in claims, not just buy it.
Klara: And "earned" means evidence first, positioning second — always.
Marco: Substantiation, identity, distribution, and consumer shifts. That's the whole game, right there.